Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma
Fergus Noble(University Hospital Southampton NHS Foundation Trust), Jamie Kelly(University Hospital Southampton NHS Foundation Trust), James Byrne, Vijayendran Sujendran, Jan Bornschein(John Radcliffe Hospital), Izhar Bagwan(Royal Surrey County Hospital), J. Robert O’Neill(Edinburgh Royal Infirmary), Stephen J. Hayes(Salford Royal NHS Foundation Trust), David Gilligan(University of Cambridge), Sarah Oakes(Royal Surrey County Hospital), Jason Crawte(University of Cambridge), Yeng Ang(The University of Texas MD Anderson Cancer Center), Vicki Save(Edinburgh Royal Infirmary), Tim Underwood(Southampton General Hospital), Richard Turkington(Queen's University Belfast), Rachel de la Rue, Shalini Malhotra(Addenbrooke's Hospital), Shaun R. Preston(Royal Surrey County Hospital), Ewen A. Griffiths(Queen Elizabeth Hospital Birmingham), Damien McManus(Queen's University Belfast), Rebecca C. Fitzgerald(Cancer Research UK), Nicholas Carroll(Cambridge University Hospitals NHS Foundation Trust), Rachael Fels Elliott(University of Cambridge), Zarah Abdullahi(University of Cambridge), Andrew Hindmarsh(Cambridge University Hospitals NHS Foundation Trust), Paul A. Edwards(University of Cambridge), Philippe Tanière(University Hospitals Birmingham NHS Foundation Trust), Christopher J. Peters(Imperial College London), Gianmarco Contino(University of Cambridge), Ahmad Miremadi(Addenbrooke's Hospital), Richard J.E. Skipworth(Edinburgh Royal Infirmary), Susana Puig(Instituto de Salud Carlos III), Hugo Ford(Cambridge University Hospitals NHS Foundation Trust), Ted R. Hupp(Edinburgh Cancer Research), Barbara Nutzinger(University of Cambridge), Shona MacRae(Hutchison/MRC Research Centre), Rob F. Walker(University of Southampton), G Hannah(Imperial College London), Megan Lloyd(University of Southampton), A Noorani(University of Cambridge), Annette Hayden(Southampton General Hospital), Peter Safranek, S Mercer(Portsmouth Hospitals NHS Trust), Simon L. Parsons(Galapagos (Belgium)), J Whiting(University Hospitals Birmingham NHS Foundation Trust), Maria O’Donovan(Addenbrooke's Hospital), Nicola Grehan(University of Cambridge), Richard Hardwick(Addenbrooke's Hospital), M Bedford(University Hospitals Birmingham NHS Foundation Trust)
Cited by 108
Related Papers
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus
|Gut|2013|1.3k
Oesophageal cancer
|Nature Reviews Disease Primers|2017|1.1k